Viemed Healthcare, Inc.

VMD · Nasdaq · ·

Karşılaştır

$9,19+%0,813 Kas kapanış

30 Eylül 2026 tarihine kadarki rakamlar, 4 Kasım 2026 tarihinde sunulan 10-Q raporundan

1W: +%0,7
1M: -%5,2

Just reported

Q3 2026 results

From Viemed Healthcare's results release of 4 Kasım 2026; its quarterly report has since been filed.

Revenue
Actual
$80,7M
+%12 y/y
+%3,3 q/q
Guided
—
No guide given
EPS, GAAP
Actual
$0,11
+%22 y/y
+%57 q/q
Guided
—
No guide given
Operating income, GAAP
Actual
$7M
+%23 y/y
+%56 q/q
Guided
—
No guide given

Company outlook

Full year 2026

Revenue$316M – $320M+%18 y/y Raised +%0,3

Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.

Keep exploring

The themes Viemed Healthcare is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.

Highest-graded in Medical Devices

Graded A or B and worth $2B or more: A first, then the largest.

All 133 graded companies in its industry

Grade rose recently in Healthcare

Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.

All grade rises

Tüm finansal tablolar →

Viemed Healthcare, Inc. şirketinin ABD Menkul Kıymetler ve Borsa Komisyonu’na (SEC) sunduğu kendi belgelerinden kuruldu. Rakamlar bildirildiği gibidir; hisse başına geçmiş bugünkü hisse tabanına göre yeniden hesaplanmıştır. Bu bir işletmeyi anlatır — yatırım tavsiyesi değildir ve alma ya da satma önerisi değildir.

Viemed Healthcare, Inc.

Viemed Healthcare, Inc.

Q3 2026 results

Revenue

EPS, GAAP